切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2021, Vol. 14 ›› Issue (05) : 380 -385. doi: 10.3877/cma.j.issn.1674-6880.2021.05.006

论著

血管外肺水含量变化与急性呼吸窘迫综合征患者预后的临床研究
宗立永1, 刘爱敏2, 丁士芳3,(), 吴大玮3, 李琛3, 翟茜3, 杜滨锋3, 李远3   
  1. 1. 256400 山东淄博,桓台县人民医院重症医学科
    2. 250031 济南,山东省立第三医院重症医学科
    3. 250000 济南,山东大学齐鲁医院重症医学科
  • 收稿日期:2021-02-19 出版日期:2021-10-31
  • 通信作者: 丁士芳
  • 基金资助:
    国家临床重点专科建设项目(2011-873); 山东省自然科学基金项目(ZR2013HM088); 天普研究基金项目(UF201304)

Clinical study on extrtravascular lung water content and prognosis of patients with acute respiratory distress syndrome

Liyong Zong1, Aimin Liu2, Shifang Ding3,(), Dawei Wu3, Chen Li3, Qian Zhai3, Binfeng Du3, Yuan Li3   

  1. 1. Department of Critical Care Medicine, Huantai County People's Hospital, Zibo 256400, China
    2. Department of Critical Care Medicine, Shandong ProvincialThird Hospital, Ji'nan 250031, China
    3. Department of Critical Care Medicine, Qilu Hospital of Shandong University, Ji'nan 250000, China
  • Received:2021-02-19 Published:2021-10-31
  • Corresponding author: Shifang Ding
引用本文:

宗立永, 刘爱敏, 丁士芳, 吴大玮, 李琛, 翟茜, 杜滨锋, 李远. 血管外肺水含量变化与急性呼吸窘迫综合征患者预后的临床研究[J]. 中华危重症医学杂志(电子版), 2021, 14(05): 380-385.

Liyong Zong, Aimin Liu, Shifang Ding, Dawei Wu, Chen Li, Qian Zhai, Binfeng Du, Yuan Li. Clinical study on extrtravascular lung water content and prognosis of patients with acute respiratory distress syndrome[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2021, 14(05): 380-385.

目的

观察急性呼吸窘迫综合征(ARDS)患者住院期间血管外肺水指数(EVLWI)和肺血管通透性指数(PVPI)对ARDS患者预后的预测价值。

方法

回顾性分析2010年1月至2017年12月入住山东大学齐鲁医院ICU的71例ARDS患者,根据患者预后情况,将其分为存活组(29例)和死亡组(42例)。比较两组患者的一般资料、液体平衡量及机械通气设置情况。采用多因素Logistic回归分析影响ARDS患者预后的危险因素;绘制受试者工作特征(ROC)曲线,评价各影响因素对ARDS患者预后的诊断价值。

结果

存活组和死亡组患者年龄、免疫功能低下病史、脓毒性休克、连续肾脏替代疗法(CRRT)、肺源性ARDS、重度ARDS、7 d总液体平衡量、前3天EVLWI和PVPI、动脉血二氧化碳分压、气道峰压以及氧合指数比较,差异均有统计学意义(P均< 0.05)。多因素Logistic回归分析结果显示,年龄[比值比(OR)= 1.190,95%置信区间(CI)(1.053,1.346),P = 0.005]、免疫功能低下病史[OR = 0.076,95%CI(0.006,0.925),P = 0.011]、第1天EVLWI[OR = 1.078,95% CI(0.978,1.188),P = 0.013]、第2天EVLWI[OR = 1.109,95% CI(1.014,1.214),P = 0.023]、第3天EVLWI[OR = 1.115,95% CI(1.015,1.226),P = 0.024]、第1天PVPI[OR = 2.048,95%CI(1.167,3.595),P = 0.012]、第2天PVPI[OR = 2.070,95%CI(1.187,3.611),P = 0.010]、第3天PVPI[OR = 2.366,95%CI(1.271,4.404),P = 0.007]、氧合指数[OR = 0.973,95%CI(0.957,0.989),P = 0.002]是影响ARDS患者预后的独立危险因素,CRRT[OR = 10.404,95%CI(1.709,63.347),P = 0.001]则是其保护因素。ROC曲线分析结果显示,年龄[曲线下面积(AUC)= 0.677,95%CI(0.546,0.809),P = 0.013]、免疫功能低下病史[AUC = 0.641,95%CI(0.512,0.770),P = 0.048]、CRRT[AUC = 0.711,95%CI(0.573,0.792),P = 0.046]、第1天EVLWI[AUC = 0.743,95%CI(0.607,0.861),P = 0.001]、第2天EVLWI[AUC = 0.763,95%CI(0.641,0.884),P < 0.001]、第3天EVLWI[AUC = 0.734,95%CI(0.613,0.855),P = 0.001]、第1天PVPI[AUC = 0.711,95%CI(0.586,0.837),P = 0.004]、第2天PVPI[AUC = 0.755,95%CI(0.633,0.877),P < 0.001]、第3天PVPI[AUC = 0.793,95%CI(0.686,0.901),P < 0.001]、氧合指数[AUC = 0.687,95%CI(0.611,0.854),P = 0.041]均对ARDS患者预后具有一定的预测价值。

结论

年龄、免疫功能低下病史、CRRT、EVLWI、PVPI及氧合指数均为ARDS患者预后的影响因素,且动态观察EVLWI、PVPI变化对判断ARDS患者的预后更具有指导意义。

Objective

To observe the prognostic value of extravascular lung water index (EVLWI) and pulmonary vascular permeability index (PVPI) in patients with acute respiratory distress syndrome (ARDS) during hospitalization.

Methods

A total of 71 patients with ARDS admitted to the ICU of Qilu Hospital of Shandong University from January 2010 to December 2017 were retrospectively analyzed. According to their prognosis, 71 patients were divided into a living group (n = 29) and a death group (n = 42). The general data, fluid balance volume and mechanical ventilation settings were compared between the two groups. Multivariate Logistic regression was used to analyze risk factors influencing the prognosis of ARDS patients, and the receiver operating characteristic (ROC) curve was drawn to evaluate their diagnostic value.

Results

The age, immune dysfunction, septic shock, continuous renal replacement therapy(CRRT), lung-derived ARDS, severe ARDS, total fluid balance of 7 d, EVLWI and PVPI at the first 3 days, arterial partial pressure of carbon dioxide, airway peaks and oxygenation index were statistically significantly different between the living group and death group (all P < 0.05). Multivariate Logistic regression analysis showed that the age [odds ratio (OR) = 1.190, 95% confidence interval (CI) (1.053, 1.346), P = 0.005], immune dysfunction [OR = 0.076, 95%CI (0.006, 0.925), P = 0.011], EVLWI on day 1 [OR = 1.078, 95%CI (0.978, 1.188), P = 0.013], EVLWI on day 2 [OR = 1.109, 95%CI (1.014, 1.214), P = 0.023], EVLWI on day 3 [OR = 1.115, 95%CI (1.015, 1.226), P = 0.024], PVPI on day 1 [OR = 2.048, 95%CI (1.167, 3.595), P = 0.012], PVPI on day 2 [OR = 2.070, 95%CI (1.187, 3.611), P = 0.010], PVPI on day 3 [OR = 2.366, 95%CI (1.271, 4.404), P = 0.007] and oxygenation index [OR = 0.973, 95%CI (0.957, 0.989), P = 0.002] were independent risk factors influencing the prognosis of ARDS patients, while CRRT [OR = 10.404, 95%CI (1.709, 63.347), P = 0.001] was the protective factor. ROC curve analysis showed that the age [area under the curve (AUC) = 0.677, 95%CI (0.546, 0.809), P = 0.013], immune dysfunction [AUC = 0.641, 95%CI (0.512, 0.770), P = 0.048], CRRT [AUC = 0.711, 95%CI (0.573, 0.792), P = 0.046], EVLWI on day 1 [AUC = 0.743, 95%CI (0.607, 0.861), P = 0.001], EVLWI on day 2 [AUC = 0.763, 95%CI (0.641, 0.884), P < 0.001], EVLWI on day 3 [AUC = 0.734, 95%CI (0.613, 0.855), P = 0.001], PVPI on day 1 [AUC = 0.711, 95%CI (0.586, 0.837), P = 0.004], PVPI on day 2 [AUC = 0.755, 95%CI (0.633, 0.877), P < 0.001], PVPI on day 3 [AUC = 0.793, 95%CI (0.686, 0.901), P < 0.001] and oxygenation index [AUC = 0.687, 95%CI (0.611, 0.854), P = 0.041] all had certain predictive value for ARDS patients.

Conclusion

Age, immune dysfunction, CRRT, EVLWI, PVPI and oxygenation index are influencing factors for the prognosis of ARDS patients, and dynamic observation of EVLWI and PVPI changes is more significant in judging their prognosis.

表1 两组ARDS患者的一般临床资料比较(±s
组别 例数 年龄(岁) 性别(例,男/女) 高血压史(例) 糖尿病史(例) 免疫功能低下病史(例) 脓毒性休克(例) APACHEⅡ评分(分) 白细胞计数(× 109/L) C反应蛋白(μg/L)
存活组 29 50 ± 17 16/13 6 4 1 19 24 ± 7 13.7 ± 8.5 159 ± 82
死亡组 42 61 ± 17 30/12 13 8 13 38 26 ± 6 14.5 ± 8.8 192 ± 94
t/χ2/H   2.560 1.923 0.881 0.316 8.144 7.315 1.226 0.039 1.056
P   0.013 0.165 0.348 0.574 0.004 0.028 0.224 0.732 0.181
组别 例数 降钙素原[μg/L,MP25P75)] CRRT(例) 肺源性ARDS(例) 重度ARDS(例) 乳酸(mmol/L) 7 d总液体平衡量[mL,MP25P75)] 第1天EVLWI(mL/kg) 第2天EVLWI(mL/kg) 第3天EVLWI(mL/kg)
存活组 29 9.6(0.5,10.0) 8 12 9 3.7 ± 2.9 4 280(1 212,7 080) 12.5 ± 7.6 12.4 ± 8.5 12.3 ± 5.2
死亡组 42 10.0(0.5,12.5) 20 32 31 3.3 ± 2.6 6 058(4 280,9 354) 18.2 ± 8.3 19.2 ± 9.7 20.0 ± 11.6
t/χ2/H   0.450 2.818 6.419 12.032 0.591 0.952 2.912 3.034 3.242
P   0.713 0.013 0.003 0.001 0.556 0.045 0.005 0.003 0.002
组别 例数 第1天PVPI 第2天PVPI 第3天PVPI PaCO2(mmHg) 气道峰压(cmH2O) 潮气量(mL/kg PBW) 呼气末正压(cmH2O) 氧合指数(mmHg)
存活组 29 2.4 ± 1.2 2.3 ± 1.3 2.1 ± 0.9 38 ± 10 25 ± 6 7.8 ± 1.1 9±4 144 ± 60
死亡组 42 3.6 ± 1.6 3.6 ± 1.7 3.9 ± 2.0 45 ± 19 29 ± 7 7.5 ± 1.3 11 ± 5 88 ± 44
t/χ2/H   3.338 3.602 0.933 2.028 2.775 1.540 1.837 2.282
P   0.001 0.001 0.034 0.046 0.005 0.253 0.071 0.026
表2 多因素Logistic回归分析影响ARDS患者预后的危险因素
表3 ROC曲线分析ARDS患者预后影响因素的预测价值
1
Phua J, Badia JR, Adhikari NK, et al. Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review[J]. Am J Respir Crit Care Med, 2009, 179 (3): 220-227.
2
Chiumello D, Marino A, Cammaroto A. The acute respiratory distress syndrome: diagnosis and management[M]. Berlin: Springer, 2019: 189-204.
3
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition[J]. JAMA, 2012, 307 (23): 2526-2533.
4
Kushimoto S, Endo T, Yamanouchi S, et al. Relationship between extravascular lung water and severity categories of acute respiratory distress syndrome by the Berlin definition[J]. Crit Care, 2013, 17 (4): R132.
5
俞森洋.对急性呼吸窘迫综合征诊断新标准(柏林定义)的解读和探讨[J].中国呼吸与危重监护杂志201312(1):1-4.
6
Luh SP, Chiang CH. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies[J]. J Zhejiang Univ Sci B, 2007, 8 (1): 60-69.
7
Laffey JG, Misak C, Kavanagh BP. Acute respiratory distress syndrome[J]. BMJ, 2017 (359): j5055.
8
Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43 (3): 304-377.
9
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39 (2): 165-228.
10
蔡毅峰,陈科署,陈佳炜,等.血管外肺水指数和肺血管通透性指数在急性呼吸窘迫综合征评估中的临床应用[J/CD].中华肺部疾病杂志(电子版)201710(5):554-558.
11
孙丽晓,高心晶,李智伯,等.血管外肺水指数对急性呼吸窘迫综合征患者预后的评价[J].中华危重病急救医学201426(2):101-105.
12
Berkowitz DM, Danai PA, Eaton S, et al. Accurate characterization of extravascular lung water in acute respiratory distress syndrome[J]. Crit Care Med, 2008, 36 (6): 1803-1809.
13
Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment[J]. JAMA, 2018: 319 (7): 698-710.
14
Rivers EP. Fluid-management strategies in acute lung injure—iberal, conservative, or both?[J]. N Engl J Med, 2006, 354 (24): 2598-2600.
15
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treament of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345 (19): 1368-1377.
16
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al. Comparison of two fluid-management strategies in acute lung injury[J]. N Engl J Med, 2006, 354 (24): 2564-2575.
17
王澄,张晓毳.血管外肺水和胸腔内血容量参数的监测及临床意义[J].中华危重病急救医学201325(5):319-320.
18
Murphy CV, Schramm GE, Doherty JA, et al. The importance of fluid management in acute lung injury secondary to septic shock[J]. Chest, 2009, 136 (1): 102-109.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[3] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[4] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[9] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[10] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[11] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[12] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要